ecancer

Next generation PI3 kinase inhibition

Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US

19 Apr 2013

Targeting tumour suppressor genes

Dr Douglas Lowy - National Cancer Institute, Bethesda, USA

19 Apr 2013

Robotic oesophagectomy

Dr Kemp Kernstine - University of Texas Southwestern Medical Center, United States

19 Dec 2012

Benefits of partaking in clinical trials

Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK

15 Nov 2012

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France

9 Oct 2012

The first phase II trial for the management of oesophageal cancer

Prof David Ferry – New Cross Hospital, Wolverhampton, UK

8 Oct 2012

Gefitinib versus placebo in oesophageal cancer progressing after chemotherapy

Prof David Ferry - New Cross Hospital, Wolverhampton, UK

29 Sep 2012

Landscape of cancer care in Bangladesh

Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh

20 Jul 2012

Importance of cancer prevention

Prof Murat Tuncer - Hacettepe University, Ankara, Turkey

20 Jul 2012

Vandetanib increases progression free survival in medullary thyroid carcinoma

Dr Nick Botwood - AstraZeneca, UK

13 Jul 2012

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK

15 Jun 2012

Developing new support services for young people with cancer

Prof Daniel Kelly - Cardiff University, UK and EONS

10 May 2012

More from ecancer